Diversity of metabolic syndrome risk factors in obese children and adolescents. 2006

G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
Departamento de Pediatría, Universidad de Zaragoza, C/ Domingo Miral s/n, 50009 Zaragoza, Spain.

The aim of this study was to investigate the frequency of metabolic syndrome (MS) variables in a group of spanish obese children and adolescents, to asses MS prevalence in this population and to describe it's relationship with other metabolic risk factors. 103 children were studied : 54 male and 49 female, mean age 10.08+/-2.3 with exogenous obesity. Obesity was defined when BMI was higher than the age and sex specific equivalent to 30 kg/m(2) in adults. MS variables considered were waist circumference, blood pressure, fasting blood triglycerides, fasting glucose/insulin and HDL-cholesterol. The children were considered as having the MS when three or more characteristics showed abnormal values according to Cook and De Ferranti definitions. HOMA index, ApoB and ApoA1 were studied too. The most frequent features of the metabolic syndrome were excess waist circumference and hypertension. The MS markers with the lowest frequency were dyslipidemia and fasting hyperglicemia. MS prevalence was 29,9% (Cook et al. criteria) and 50% (De Ferranti et al. criteria). Fasting insulin and HOMA index values increased significantly (p < 0.05) when three or more abnormalities of the MS variables were present. Apo B increased significantly only in females (p < 0.05) and Apo Al decreased significantly (p < 0.05) in both sexes when MS was present. Adequate metabolic syndrome risk factors criteria, mainly cut-off values, need to be defined in the European paediatric population.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
July 2015, Journal of pediatric endocrinology & metabolism : JPEM,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2015, Srpski arhiv za celokupno lekarstvo,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2013, Nutrition journal,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2012, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2021, Frontiers in pediatrics,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2021, International journal of environmental research and public health,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2014, Diabetes, metabolic syndrome and obesity : targets and therapy,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
February 2013, European journal of pediatrics,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
August 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
G Bueno, and O Bueno, and L A Moreno, and R García, and B Tresaco, and J M Garagorri, and M Bueno
January 2012, La Tunisie medicale,
Copied contents to your clipboard!